Published in World Neurosurg on July 01, 2010
Treatment of hyperprolactinemia: a systematic review and meta-analysis. Syst Rev (2012) 0.82
Comprehensive review of stereotactic radiosurgery for medically and surgically refractory pituitary adenomas. Surg Neurol Int (2012) 0.79
Radiosurgery: a useful first-line treatment of prolactinomas? World Neurosurg (2010) 0.79
Target delineation and optimal radiosurgical dose for pituitary tumors. Radiat Oncol (2016) 0.75
Approach to the management of rare clinical presentations of macroprolactinomas in reproductive-aged women. Case Rep Womens Health (2015) 0.75
Stereotactic radiotherapy and radiosurgery for non-functioning and secreting pituitary adenomas. Rep Pract Oncol Radiother (2014) 0.75
Effects of preoperative bromocriptine treatment on prolactin-secreting pituitary adenoma surgery. Exp Ther Med (2016) 0.75
Management of hormone-secreting pituitary adenomas. Neuro Oncol (2017) 0.75
A randomized trial of bevacizumab for newly diagnosed glioblastoma. N Engl J Med (2014) 9.19
Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab (2008) 6.48
Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: a multi-institutional analysis of 4,259 patients. Int J Radiat Oncol Biol Phys (2009) 6.11
Randomized trial of radiation therapy plus procarbazine, lomustine, and vincristine chemotherapy for supratentorial adult low-grade glioma: initial results of RTOG 9802. J Clin Oncol (2012) 4.27
Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases. J Clin Oncol (2011) 4.12
The relationship between six-month progression-free survival and 12-month overall survival end points for phase II trials in patients with glioblastoma multiforme. Neuro Oncol (2006) 3.83
A t(1;19)(q10;p10) mediates the combined deletions of 1p and 19q and predicts a better prognosis of patients with oligodendroglioma. Cancer Res (2006) 3.83
Dose-dense temozolomide for newly diagnosed glioblastoma: a randomized phase III clinical trial. J Clin Oncol (2013) 3.52
A model to determine workforce needs for endocrinologists in the United States until 2020. J Clin Endocrinol Metab (2003) 3.38
A comparison of biochemical tests for pheochromocytoma: measurement of fractionated plasma metanephrines compared with the combination of 24-hour urinary metanephrines and catecholamines. J Clin Endocrinol Metab (2003) 3.25
Use of an orthotopic xenograft model for assessing the effect of epidermal growth factor receptor amplification on glioblastoma radiation response. Clin Cancer Res (2006) 3.15
Role and relevance of neurocognitive assessment in clinical trials of patients with CNS tumors. J Clin Oncol (2006) 2.83
An expert consensus statement on use of adrenal vein sampling for the subtyping of primary aldosteronism. Hypertension (2013) 2.72
Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab (2014) 2.72
Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. J Clin Endocrinol Metab (2004) 2.56
Radiosurgery to the postoperative surgical cavity: who needs evidence? Int J Radiat Oncol Biol Phys (2011) 2.21
Malignant pheochromocytoma: current status and initiatives for future progress. Endocr Relat Cancer (2004) 2.20
Multiple sclerosis, brain radiotherapy, and risk of neurotoxicity: the Mayo Clinic experience. Int J Radiat Oncol Biol Phys (2006) 2.12
Stereotactic radiosurgery for trigeminal pain secondary to benign skull base tumors. World Neurosurg (2012) 1.99
Mediastinal paragangliomas: the mayo clinic experience. Ann Thorac Surg (2008) 1.95
Stereotactic body radiation therapy for management of spinal metastases in patients without spinal cord compression: a phase 1-2 trial. Lancet Oncol (2012) 1.90
Validation of single-item linear analog scale assessment of quality of life in neuro-oncology patients. J Pain Symptom Manage (2007) 1.83
Cervical spondylotic myelopathy: a brief review of its pathophysiology, clinical course, and diagnosis. Neurosurgery (2007) 1.76
Phase II trial of procarbazine, lomustine, and vincristine as initial therapy for patients with low-grade oligodendroglioma or oligoastrocytoma: efficacy and associations with chromosomal abnormalities. J Clin Oncol (2003) 1.76
Bilateral laparoscopic adrenalectomy for corticotrophin-dependent Cushing's syndrome: a review of the Mayo Clinic experience. Clin Endocrinol (Oxf) (2007) 1.75
Effect of tumor subtype on survival and the graded prognostic assessment for patients with breast cancer and brain metastases. Int J Radiat Oncol Biol Phys (2011) 1.74
Primary aldosteronism: diagnostic and treatment strategies. Nat Clin Pract Nephrol (2006) 1.72
Pituitary carcinoma: a clinicopathological review. Neurosurgery (2005) 1.70
Benzoic acid glucosinolate esters and other glucosinolates from Arabidopsis thaliana. Phytochemistry (2002) 1.69
Clinical review 164: The laboratory diagnosis of adrenal pheochromocytoma: the Mayo Clinic experience. J Clin Endocrinol Metab (2003) 1.68
Utility of PET/CT imaging performed early after surgical resection in the adjuvant treatment planning for head and neck cancer. Int J Radiat Oncol Biol Phys (2007) 1.65
Central nervous system tumors. Mayo Clin Proc (2007) 1.61
Use of antithrombotic agents in patients with intracerebral cavernous malformations. J Neurosurg (2012) 1.60
Plasma chromogranin A or urine fractionated metanephrines follow-up testing improves the diagnostic accuracy of plasma fractionated metanephrines for pheochromocytoma. J Clin Endocrinol Metab (2007) 1.60
Silver nanoparticles and polymeric medical devices: a new approach to prevention of infection? J Antimicrob Chemother (2004) 1.58
A double-blind, randomized study comparing the antihypertensive effect of eplerenone and spironolactone in patients with hypertension and evidence of primary aldosteronism. J Hypertens (2011) 1.57
A comparison of surgical resection and stereotactic radiosurgery in the treatment of solitary brain metastases. Int J Radiat Oncol Biol Phys (2003) 1.55
Dexamethasone-suppressed corticotropin-releasing hormone stimulation test for diagnosis of mild hypercortisolism. J Clin Endocrinol Metab (2007) 1.54
Radiation-induced sarcoma in a large vestibular schwannoma following stereotactic radiosurgery: case report. Neurosurgery (2011) 1.53
Selective serotonin reuptake inhibitors, glioblastoma multiforme, and impact on toxicities and overall survival: the mayo clinic experience. Am J Clin Oncol (2011) 1.45
Radiosurgery for large-volume (> 10 cm3) benign meningiomas. J Neurosurg (2010) 1.45
Pheochromocytoma and paraganglioma in children: a review of medical and surgical management at a tertiary care center. Pediatrics (2006) 1.45
Patient outcomes after vestibular schwannoma management: a prospective comparison of microsurgical resection and stereotactic radiosurgery. Neurosurgery (2006) 1.42
Pituitary tumor type affects the chance of biochemical remission after radiosurgery of hormone-secreting pituitary adenomas. Neurosurgery (2008) 1.42
Gastric stromal tumors in Carney triad are different clinically, pathologically, and behaviorally from sporadic gastric gastrointestinal stromal tumors: findings in 104 cases. Am J Surg Pathol (2010) 1.41
Arteriovenous malformations and radiosurgery. J Neurosurg (2013) 1.40
Stereotactic radiosurgery for patients with ACTH-producing pituitary adenomas after prior adrenalectomy. Int J Radiat Oncol Biol Phys (2002) 1.38
Recurrence following neurosurgeon-determined gross-total resection of adult supratentorial low-grade glioma: results of a prospective clinical trial. J Neurosurg (2008) 1.37
Impact of preoperative embolization on outcomes of carotid body tumor resections. J Vasc Surg (2012) 1.36
Reversible, strokelike migraine attacks in patients with previous radiation therapy. Neuro Oncol (2003) 1.36
Management of brain metastases from thyroid carcinoma: a study of 16 pathologically confirmed cases over 25 years. Cancer (2003) 1.32
Radiosurgery for arteriovenous malformations of the basal ganglia, thalamus, and brainstem. J Neurosurg (2004) 1.31
Phase I trial of erlotinib with radiation therapy in patients with glioblastoma multiforme: results of North Central Cancer Treatment Group protocol N0177. Int J Radiat Oncol Biol Phys (2006) 1.28
The natural history of radiographically defined vertebrobasilar nonsaccular intracranial aneurysms. Cerebrovasc Dis (2005) 1.26
Effect of the addition of chemotherapy to radiotherapy on cognitive function in patients with low-grade glioma: secondary analysis of RTOG 98-02. J Clin Oncol (2014) 1.24
A prospective study of quality of life in adults with newly diagnosed high-grade gliomas: the impact of the extent of resection on quality of life and survival. Neurosurgery (2005) 1.23
The aldosteronoma resolution score: predicting complete resolution of hypertension after adrenalectomy for aldosteronoma. Ann Surg (2008) 1.23
Adrenal incidentaloma. Curr Opin Oncol (2003) 1.23
Cognitive sequelae of brain radiation in adults. Semin Oncol (2004) 1.22
Stereotactic radiosurgery for idiopathic trigeminal neuralgia. J Neurosurg (2002) 1.22
Hemangiopericytoma in the central nervous system: treatment, pathological features, and long-term follow up in 38 patients. J Neurosurg (2003) 1.21
Pediatric cerebellopontine angle and internal auditory canal tumors: clinical article.. J Neurosurg Pediatr (2013) 1.21
Intracranial low-grade gliomas in adults: 30-year experience with long-term follow-up at Mayo Clinic. Neuro Oncol (2008) 1.20
Pathogenesis, natural history, and treatment of unruptured intracranial aneurysms. Mayo Clin Proc (2004) 1.19
Outcome in adult low-grade glioma: the impact of prognostic factors and treatment. Neurology (2007) 1.18
Early pulmonary toxicity following lung stereotactic body radiation therapy delivered in consecutive daily fractions. Radiother Oncol (2011) 1.17
Central neurocytoma: management recommendations based on a 35-year experience. Int J Radiat Oncol Biol Phys (2006) 1.16
Proton beam radiotherapy versus three-dimensional conformal stereotactic body radiotherapy in primary peripheral, early-stage non-small-cell lung carcinoma: a comparative dosimetric analysis. Int J Radiat Oncol Biol Phys (2009) 1.15
Dysphagia, hoarseness, and unilateral true vocal fold motion impairment following anterior cervical diskectomy and fusion. Ann Otol Rhinol Laryngol (2003) 1.15
Randomized controlled trial of maintaining quality of life during radiotherapy for advanced cancer. Cancer (2012) 1.15
Pathobiology of pituitary adenomas and carcinomas. Neurosurgery (2006) 1.13
A study on the radiation tolerance of the optic nerves and chiasm after stereotactic radiosurgery. Int J Radiat Oncol Biol Phys (2003) 1.13
Stereotactic radiosurgery for patients with "radioresistant" brain metastases. Neurosurgery (2002) 1.12
Biopsy of pheochromocytomas and paragangliomas: potential for disaster. Surgery (2009) 1.11
Endovascular treatment of an internal carotid artery pseudoaneurysm following transsphenoidal surgery. Case report. J Neurosurg (2002) 1.10
Editorial: paraganglioma--all in the family. J Clin Endocrinol Metab (2006) 1.09
Ganglioglioma in the cerebellopontine angle in a child. Case report and review of the literature. J Neurosurg (2007) 1.09
Combination of temsirolimus (CCI-779) with chemoradiation in newly diagnosed glioblastoma multiforme (GBM) (NCCTG trial N027D) is associated with increased infectious risks. Clin Cancer Res (2010) 1.08
Functioning paraganglioma and gastrointestinal stromal tumor of the jejunum in three women: syndrome or coincidence. Am J Surg Pathol (2006) 1.08
Stereotactic radiosurgery for brainstem metastases: Survival, tumor control, and patient outcomes. Int J Radiat Oncol Biol Phys (2006) 1.08
Lipomas of the cerebellopontine angle and internal auditory canal: Primum Non Nocere. Laryngoscope (2013) 1.08
Phase 1/2 trial of single-session stereotactic body radiotherapy for previously unirradiated spinal metastases. Cancer (2012) 1.08
Pheochromocytomas and paragangliomas in von Hippel-Lindau disease: a role for laparoscopic and cortical-sparing surgery. Arch Surg (2002) 1.07
Validation of EORTC prognostic factors for adults with low-grade glioma: a report using intergroup 86-72-51. Int J Radiat Oncol Biol Phys (2011) 1.07
Role of camalexin, indole glucosinolates, and side chain modification of glucosinolate-derived isothiocyanates in defense of Arabidopsis against Sclerotinia sclerotiorum. Plant J (2011) 1.07